Trial intelligence / Profile preview

Levofloxacin Prophylaxis Before PCNL

NCT03178292Unknown

Sponsor
Mansoura University
Start
Jun 2017
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in urinary tract infection (UTI) and sepsis comparing Levofloxacin with Placebo (2 arms). Primary endpoint: Upper urinary tract infection and systemic inflammatory response syndrome (SIRS) at 1 year. Status: unknown.

02

Drugs

levofloxacin
03

Conditions

urinary tract infection (UTI)sepsis

Beyond the preview

Go deeper on NCT03178292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03178292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call